Dianthus Therapeutics Banner

SEC Filing Details

Dianthus Therapeutics, Inc. Announces Closing of its Upsized $719 Million Underwritten Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

Document Details

Form
Filing Date
Apr 1, 2026
Document Date
Mar 31, 2026
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Dianthus Therapeutics
Issuer
DIANTHUS THERAPEUTICS, INC. /DE/
Filer
Soteropoulos Paula